Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Mankind Pharma
Acquired Company
ActX
Description
Mankind Pharma has agreed to acquire a 70% stake in Belgium-based ACTx for ₹511 crore. The deal aims to enhance Mankind's portfolio in next-generation cancer therapies. This acquisition will be executed through Mankind Pharma's wholly owned subsidiary in the Netherlands. It reflects Mankind's commitment to advancing innovative treatments for cancer.
Fundz sees it the moment Mankind Pharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired ActX?
ActX was acquired by Mankind Pharma, based in New Delhi. The deal was reported on October 15, 2026. Mankind Pharma is a pharmaceutical company that has completed the transaction to acquire Bharat Serums and Vaccines Ltd (BSV), for a consideration of ₹13,768 crore. Mankind Pharma is privately held and operates in Biotechnology.
When did Mankind Pharma acquire ActX?
Mankind Pharma's acquisition of ActX was reported on October 15, 2026. Mankind Pharma has agreed to acquire a 70% stake in Belgium-based ACTx for ₹511 crore. The deal aims to enhance Mankind's portfolio in next-generation cancer therapies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does ActX do?
ActX, Inc. is a dynamic venture that is focused on making patient genomic information truly useful in everyday medical practice. It is privately held, operating in Healthcare, and is based in Seattle.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.